A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The primary objective of the study is to assess pharmacokinetics, dynamics, safety and tolerability of CiVi007 following single and multiple subcutaneous doses in subjects, including those on statin therapy
Epistemonikos ID: d56901b45357b064de12240053589d284ece033a
First added on: May 21, 2024